scholarly article | Q13442814 |
P819 | ADS bibcode | 1989Sci...246..670W |
P356 | DOI | 10.1126/SCIENCE.2530630 |
P3181 | OpenCitations bibliographic resource ID | 1915078 |
P698 | PubMed publication ID | 2530630 |
P5875 | ResearchGate publication ID | 20624781 |
P2093 | author name string | J. Pohl | |
K. D. Wilkinson | |||
K. M. Lee | |||
J. M. Boss | |||
P. Duerksen-Hughes | |||
S. Deshpande | |||
P433 | issue | 4930 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thiol-dependent deubiquitinase | Q21097542 |
Ubiquitin C-terminal hydrolase L3 | Q21126400 | ||
P304 | page(s) | 670–673 | |
P577 | publication date | 1989-11-03 | |
P1433 | published in | Science | Q192864 |
P1476 | title | The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase | |
P478 | volume | 246 |
Q48654053 | 'Neuron-specific' protein gene product 9.5 (PGP 9.5) is also expressed in glioma cell lines and its expression depends on cellular growth state |
Q43964308 | 5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice |
Q30490465 | 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice |
Q58266607 | A Novel UbiquitinC‐terminal Hydrolase (UCH‐9) from Chick Skeletal Muscle: Its Purification and Characterization |
Q28579366 | A comparative proteomic analysis of the rat brain during rebound hyperphagia induced by space-restriction |
Q28307027 | A human de-ubiquitinating enzyme with both isopeptidase and peptidase activities in vitro |
Q28359750 | A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14 |
Q32026630 | A novel family of ubiquitin-specific proteases in chick skeletal muscle with distinct N- and C-terminal extensions |
Q47250022 | A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury |
Q48281867 | A novel ubiquitin carboxyl terminal hydrolase is involved in toad oocyte maturation |
Q33851008 | A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases |
Q33657708 | A panel of neuron-enriched proteins as markers for traumatic brain injury in humans |
Q37364019 | A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy |
Q41484383 | A qualitative and quantitative protein database approach identifies individual and groups of functionally related proteins that are differentially regulated in simian virus 40 (SV40) transformed human keratinocytes: an overview of the functional cha |
Q28579006 | A role of the ubiquitin-proteasome system in neuropathic pain |
Q44687536 | A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation |
Q34449989 | A ubiquitin-specific protease that efficiently cleaves the ubiquitin-proline bond. |
Q35676668 | Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy |
Q40016575 | Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. |
Q36489525 | Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury |
Q46287754 | Abnormal development of tracheal innervation in rats with experimental diaphragmatic hernia |
Q33861095 | Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes. |
Q36601348 | Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells |
Q37038143 | Acute damage by naphthalene triggers expression of the neuroendocrine marker PGP9.5 in airway epithelial cells |
Q48392755 | Adaptations in the structure and innervation of follicle-sinus complexes to an aquatic environment as seen in the Florida manatee (Trichechus manatus latirostris). |
Q42983677 | Affinity purification and characterization of protein gene product 9.5 (PGP9.5) from retina |
Q44410269 | Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants |
Q37287264 | Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model |
Q48454804 | Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway |
Q28507932 | Altered neuronal lineages in the facial ganglia of Hoxa2 mutant mice |
Q42050045 | Amyloid beta precursor protein and ubiquitin epitopes in human and experimental dystrophic axons. Ultrastructural localization |
Q52552277 | An Intact Intermediate Filament Network Is Required for Collateral Sprouting of Small Diameter Nerve Fibers |
Q37169940 | Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis. |
Q37677423 | Angiotensin II receptor type 2 activation is required for cutaneous sensory hyperinnervation and hypersensitivity in a rat hind paw model of inflammatory pain |
Q42554129 | Assesment of protein gene product (pgp9.5) enzyme activity against potential Peptide substrate |
Q37036740 | Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies |
Q37424589 | Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis |
Q44735189 | Axonal transport of two major components of the ubiquitin system: free ubiquitin and ubiquitin carboxyl-terminal hydrolase PGP 9.5 |
Q39326560 | Aβ1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation |
Q38299281 | Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1. |
Q36488715 | Biology of mitochondria in neurodegenerative diseases |
Q39061827 | Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids |
Q35885458 | Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood |
Q30778432 | Biotin-ubiquitin tagging of mammalian proteins in Escherichia coli |
Q40561495 | Bone morphogenetic protein-2 and -4 limit the number of enteric neurons but promote development of a TrkC-expressing neurotrophin-3-dependent subset. |
Q34555158 | Bone morphogenetic proteins regulate enteric gliogenesis by modulating ErbB3 signaling |
Q28201838 | Catalog of 680 variations among eight cytochrome P450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population |
Q34044055 | Cell surface control of the multiubiquitination and deubiquitination of high-affinity immunoglobulin E receptors |
Q38219857 | Cellular ubiquitin pool dynamics and homeostasis |
Q48627058 | Changes in ubiquitin immunoreactivity in developing rat brain: a putative role for ubiquitin and ubiquitin conjugates in dendrite outgrowth and differentiation |
Q42519612 | Characterization of Meibomian gland innervation in the cynomolgus monkey (Macaca fascicularis). |
Q46599377 | Characterization of the Folding of a 52-Knotted Protein Using Engineered Single-Tryptophan Variants |
Q36662171 | Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities |
Q35681844 | Chasing genes in Alzheimer's and Parkinson's disease |
Q82534885 | Cholecystokinin-8 activates myenteric neurons in 21- and 35-day old but not 4- and 14-day old rats |
Q41679939 | Citrate-capped gold nanoparticles for the label-free detection of ubiquitin C-terminal hydrolase-1. |
Q34838291 | Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise |
Q38875965 | Concise Review: Fate Determination of Stem Cells by Deubiquitinating Enzymes |
Q39418939 | Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. |
Q37767600 | Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis |
Q45873810 | Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments |
Q33859389 | Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. |
Q38336126 | DUBs, the regulation of cell identity and disease |
Q33715071 | Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study |
Q43181970 | Decreased innervation of eczematous skin in NC/Nga atopic mice during chronic mild stress |
Q41594496 | Dental innervation: functions and plasticity after peripheral injury |
Q42145813 | Detection of ubiquityl-calmodulin conjugates with a novel high-molecular weight ubiquitylprotein-isopeptidase in rabbit tissues |
Q28188326 | Deubiquitinating enzymes--the importance of driving in reverse along the ubiquitin-proteasome pathway |
Q22008048 | Deubiquitinating enzymes: a new class of biological regulators |
Q35605740 | Deubiquitinating enzymes: their roles in development, differentiation, and disease |
Q48265884 | Deubiquitylating enzymes and drug discovery: emerging opportunities. |
Q35210052 | Development of cell markers for the identification and expansion of islet progenitor cells |
Q79148918 | Development of innervation in primary incisors in the foetal period |
Q42067000 | Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. |
Q48515235 | Developmental pattern of cell type-specific calretinin immunoreactivity in the postnatal gerbil pineal gland |
Q35551396 | Developmentally regulated loss of ubiquitin and ubiquitinated proteins during pollen maturation in maize |
Q35131671 | Diabetic neuropathy and nerve regeneration |
Q53555151 | Differential Changes in the Peptidergic and the Non-Peptidergic Skin Innervation in Rat Models for Inflammation, Dry Skin Itch, and Dermatitis. |
Q34238665 | Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy |
Q48827531 | Differential expression of brain-derived neurotrophic factor and neurotrophin 3 mRNA in lingual papillae and taste buds indicates roles in gustatory and somatosensory innervation |
Q28581651 | Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons |
Q34375260 | Disappearance of hepatic parenchymal nerves in human liver cirrhosis. |
Q34266771 | Discovery of Inhibitors that Elucidate the Role of UCH-L1 Activity in the H1299 Lung Cancer Cell Line |
Q41892465 | Disruption of polyubiquitin gene Ubb causes dysregulation of neural stem cell differentiation with premature gliogenesis |
Q44369637 | Disruption of sonic hedgehog signaling alters growth and patterning of lingual taste papillae |
Q37030606 | Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice |
Q42371373 | Do Low Serum UCH-L1 and TDP-43 Levels Indicate Disturbed Ubiquitin-Proteosome System in Autism Spectrum Disorder? |
Q41910089 | Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons |
Q28073686 | Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases |
Q37419738 | Effect of age on the enteric nervous system of the human colon |
Q41272965 | Effect of three animal models of inflammation on nerve fibres in the synovium |
Q28647601 | Elaboration and Innervation of the Vibrissal System in the Rock Hyrax (Procavia capensis). |
Q36920753 | Emerging roles of deubiquitinating enzymes in human cancer |
Q92486636 | Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis |
Q35169530 | Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function |
Q39962010 | Endoplasmic reticulum stress contributes to the cell death induced by UCH-L1 inhibitor |
Q37126902 | Epidermal nerve fiber quantification in the assessment of diabetic neuropathy |
Q37415914 | Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma |
Q84742947 | Erythropoietin restores C-fiber function and prevents pressure ulcer formation in diabetic mice |
Q28263518 | Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins |
Q38992717 | Evaluation of intraepidermal nerve fibres in the skin of normal and atopic dogs. |
Q44396546 | Evidence that nitric oxide does not directly contribute to methacholine-induced amylase secretion in rabbit parotid acinar cells |
Q28732131 | Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1 |
Q31136191 | Experimental measles encephalitis in Lewis rats: dissemination of infected neuronal cell subtypes |
Q78554367 | Experimental study on hepatic reinnervation after orthotopic liver transplantation in rats |
Q33496702 | Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes |
Q33196999 | Expression of protein gene product 9.5 in lepromatous eyes showing ciliary body nerve damage and a "dying back" phenomenon in the posterior ciliary nerves. |
Q34317817 | Families of cysteine peptidases. |
Q28566194 | Gangliogenesis in the enteric nervous system: roles of the polysialylation of the neural cell adhesion molecule and its regulation by bone morphogenetic protein-4 |
Q37529488 | Gene expression profiling of mesenteric lymph nodes from sheep with natural scrapie |
Q36393415 | Genetic analysis of the ubiquitin system |
Q36777572 | Genetic analysis of ubiquitin-dependent protein degradation |
Q38115298 | Genetic basis of Parkinson's disease: inheritance, penetrance, and expression |
Q61852966 | Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides |
Q37680862 | Heat shock proteins and cell proliferation |
Q30317812 | Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma |
Q47921202 | High performance liquid chromatography resolution of ubiquitin pathway enzymes from wheat germ |
Q43110701 | High-throughput sample preparation for protein or peptide structural characterization |
Q71686844 | Histopathological evaluation of retinal damage during intraocular hypertension in rabbit: involvement of ganglion cells and nerve fiber layer |
Q37232888 | Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment. |
Q52188668 | Human olfactory mucosa in schizophrenia. |
Q35058256 | Hypersensitivity and hyperinnervation of the rat hind paw following carrageenan-induced inflammation |
Q89172298 | Identification of Proteins Differentially Expressed by Quercetin Treatment in a Middle Cerebral Artery Occlusion Model: A Proteomics Approach |
Q30422357 | Identification of a gene set to evaluate the potential effects of loud sounds from seismic surveys on the ears of fishes: a study with Salmo salar |
Q40053880 | Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays |
Q91649615 | Identification of proteins differentially expressed by glutamate treatment in cerebral cortex of neonatal rats |
Q45292344 | Identification of tyrosine nitration in UCH-L1 and GAPDH. |
Q73812365 | Immunocytochemical characteristics of cells and fibers in the nasal mucosa of young and adult macaques |
Q79173617 | Immunohistochemical Analysis of Protein Gene Product 9.5, a Ubiquitin Carboxyl-terminal Hydrolase, during Placental and Embryonic Development in the Mouse |
Q74598806 | Immunohistochemical and electron microscopic study of extrinsic hepatic reinnervation following orthotopic liver transplantation in rats |
Q42490746 | Immunohistochemical localization of protein gene product 9.5, ubiquitin, and neuropeptide Y immunoreactivities in epithelial and neuroendocrine cells from normal and hyperplastic human prostate |
Q67555233 | Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function |
Q73305027 | Immunohistochemical study of the regeneration process of extrinsic hepatic nerves following liver transplantation in rats |
Q79123376 | Immunohistochemistry of the canine vomeronasal organ |
Q42444287 | Immunohistochemistry of the canine vomeronasal organ |
Q64763010 | Impact of gene mutation in the development of Parkinson's disease |
Q44796900 | In vitro activation of murine DRG neurons by CGRP-mediated mucosal mast cell degranulation |
Q41982539 | Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation |
Q37136770 | Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease |
Q67524069 | Inflammation of the subacromial bursa in chronic shoulder pain |
Q53214968 | Innervation in human taste buds and its decrease in Alzheimer's disease patients. |
Q40072022 | Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response |
Q42021490 | Interstitial cells from rat middle cerebral artery belong to smooth muscle cell type |
Q30764264 | Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice |
Q21145675 | Intricate knots in proteins: Function and evolution |
Q37086732 | Knotting and unknotting of a protein in single molecule experiments. |
Q33614957 | LIM homeodomain transcription factor Isl1 directs normal pyloric development by targeting Gata3 |
Q27671821 | Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains |
Q24308558 | Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells |
Q36872963 | Libraries of random-sequence polypeptides produced with high yield as carboxy-terminal fusions with ubiquitin |
Q34587341 | Liver regeneration: immunohistochemical study of intrinsic hepatic innervation after partial hepatectomy in rats |
Q84959687 | Localization of nerve fibers in colonic polyps, adenomas, and adenocarcinomas by immunocytochemical staining for PGP 9.5. |
Q44346570 | Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex |
Q73457856 | Macrophages: a major source of cytochrome b558 in the rat carotid body |
Q33580301 | Mass spectrometry assessment of ubiquitin carboxyl-terminal hydrolase L1 partitioning between soluble and particulate brain homogenate fractions |
Q34502221 | Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases |
Q40982606 | Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line |
Q33719548 | Modelling the role of UCH-L1 on protein aggregation in age-related neurodegeneration |
Q48494522 | Molecular cloning and immunohistochemical localization of ubiquitin C-Terminal hydrolase expressed in testis of a teleost, the Nile Tilapia, Oreochromis niloticus |
Q28250790 | Molecular cloning of a novel ubiquitin-specific protease, UBP41, with isopeptidase activity in chick skeletal muscle |
Q37749063 | Molecular mechanisms of pathogenesis of Parkinson's disease. |
Q34274134 | Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C‐terminal hydrolase L3 |
Q33409559 | Multifarious proteomic signatures and regional heterogeneity in glioblastomas |
Q71977237 | Multiple Ubiquitin C-terminal Hydrolases from Chick Skeletal Muscle |
Q35193829 | N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage |
Q35993383 | Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours |
Q66811946 | Neuroimaging of traumatic brain injury in military personnel: An overview |
Q44579215 | Neuromodulation of enteropathogen internalization in Peyer's patches from porcine jejunum |
Q73937731 | Neuron-specific PGP9.5 expression in rat hair follicle development and cycle |
Q57787576 | Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury |
Q35886625 | Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling |
Q34780208 | Neuronal protein gene product 9.5 (IEF SSP 6104) is expressed in cultured human MRC-5 fibroblasts of normal origin and is strongly down-regulated in their SV40 transformed counterparts |
Q55365537 | Neuropathology of the olfactory mucosa in chronic rhinosinusitis. |
Q37605620 | Neuropeptide tyrosine in the cardiovascular system |
Q33821316 | Neuroproteomics as a promising tool in Parkinson's disease research |
Q41475859 | Neutral endopeptidase (EC 3.4.24.11) in labial salivary glands in healthy controls and in patients with Sjögren's syndrome |
Q41934170 | New de-ubiquitinating enzyme, ubiquitin C-terminal hydrolase 8, in chick skeletal muscle |
Q68719384 | New nucleotide sequence data on the EMBL File Server |
Q71651428 | Non‐enzymatic retrieval of antigen permits staining of follicle centre cells by the rabbit polyclonal antibody to protein gene product 9.5 |
Q51241428 | Novel UCHL1 mutations reveal new insights into ubiquitin processing. |
Q88596821 | Novel splice-site variant of UCHL1 in an Indian family with autosomal recessive spastic paraplegia-79 |
Q35875241 | O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat. |
Q43119443 | Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation |
Q37623718 | Organization of sensory input to the nociceptive-specific cutaneous trunk muscle reflex in rat, an effective experimental system for examining nociception and plasticity |
Q33379134 | Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells. |
Q52188862 | Overexpression of nerve growth factor in epidermis disrupts the distribution and properties of sympathetic innervation in footpads. |
Q52736642 | Overexpression of ubiquitin carboxyl terminal hydrolase impairs multiple pathways during eye development in Drosophila melanogaster. |
Q40622076 | Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway |
Q71911888 | PC12 cells show immunoreactivity to a number of proteins and peptides, including vasostatin |
Q47795752 | PGP 9.5 and cyclin D1 coexpression in cutaneous squamous cell carcinomas |
Q33728081 | PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors |
Q35787842 | PGP9.5 as a candidate tumor marker for non-small-cell lung cancer |
Q71844537 | PGP9.5, a ubiquitin C-terminal hydrolase; pattern of mRNA and protein expression during neural development in the mouse |
Q35652741 | Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells |
Q34531604 | Painful neuropathy with skin denervation after prolonged use of linezolid |
Q36055631 | Palisade endings in extraocular eye muscles revealed by SNAP-25 immunoreactivity |
Q34448273 | Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system |
Q37882593 | Parkinson's disease, proteins, and prions: milestones |
Q34140428 | Parkinson's disease: Exit toxins, enter genetics |
Q37086128 | Parkinson's disease: a genetic perspective |
Q41900145 | Partial purification and substrate specificity of a ubiquitin hydrolase from Saccharomyces cerevisiae |
Q36770206 | Pathogenic mutations in Parkinson disease |
Q36012104 | Pathological proteins in Parkinson's disease: focus on the proteasome |
Q73674887 | Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin |
Q52310775 | Performance Evaluation of a Multiplex Assay for Simultaneous Detection of Four Clinically Relevant TBI Biomarkers. |
Q41239938 | Perturbation of the ubiquitin system causes leaf curling, vascular tissue alterations and necrotic lesions in a higher plant |
Q35221892 | Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice |
Q92319238 | Placental clearance/synthesis of neurobiomarkers GFAP and UCH-L1 in healthy term neonates and those with moderate-severe neonatal encephalopathy |
Q58697859 | Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia |
Q92609250 | Plasma ubiquitin C-terminal hydrolase L1 levels reflect disease stage and motor severity in Parkinson's disease |
Q37401250 | Polyubiquitin binding and disassembly by deubiquitinating enzymes |
Q44235981 | Porcine UCHL1: genomic organization, chromosome localization and expression analysis |
Q74501947 | Postmortem changes in the immunohistochemical demonstration of nerves in human ventricular myocardium |
Q38565170 | Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma |
Q35009483 | Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. |
Q36571464 | Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. |
Q43570380 | Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients |
Q77549575 | Proteasome inhibitors which induce neurite outgrowth from PC12h cells cause different subcellular accumulations of multi-ubiquitin chains |
Q35141919 | Protein folding absent selection. |
Q46591474 | Protein gene product (PGP) 9.5 immunoreactivity in nerve fibres and pinealocytes of guinea-pig pineal gland: interrelationship with tyrosine- hydroxylase- and neuropeptide-Y-immunoreactive nerve fibres |
Q42502963 | Protein gene product 9.5 and ubiquitin immunoreactivities in rat epididymis epithelium |
Q82029470 | Protein-handling dysfunction in Parkinson's disease |
Q41288801 | Proteolysis in plants: mechanisms and functions |
Q89355462 | Proteomic Analysis of Hippocampus in a Mouse Model of Depression Reveals Neuroprotective Function of Ubiquitin C-terminal Hydrolase L1 (UCH-L1) via Stress-induced Cysteine Oxidative Modifications |
Q41325309 | Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease |
Q46087149 | Proteomics evaluation of chemically cleavable activity-based probes |
Q41606540 | Pulmonary large cell carcinoma expressing neuroendocrine markers: the morphological, biological, and neuroendocrine features of their cell lines and surgical cases |
Q41972480 | Purinoreceptor-mediated current in myocytes from renal resistance arteries. |
Q34325033 | Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration |
Q51609891 | Redistribution of Cav2.1 channels and calcium ions in nerve terminals following end-to-side neurorrhaphy: ionic imaging analysis by TOF-SIMS. |
Q48359758 | Reduction in memory in passive avoidance learning, exploratory behaviour and synaptic plasticity in mice with a spontaneous deletion in the ubiquitin C-terminal hydrolase L1 gene |
Q46875234 | Regeneration of nerve fibres across a colonic anastomosis in the guinea-pig. |
Q50750700 | Regional differences in the number of neurons in the myenteric plexus of the guinea pig small intestine and colon: an evaluation of markers used to count neurons. |
Q37357747 | Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. |
Q41760612 | Relationships between stress, protein damage, nutrition, and age-related eye diseases |
Q48085404 | Repetitious structure and transcription control of a polyubiquitin gene in Volvox carteri |
Q33215682 | Replaceable neurons and neurodegenerative disease share depressed UCHL1 levels |
Q37151410 | Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease |
Q35550995 | Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses |
Q35342904 | Role of substance P in inflammatory arthritis |
Q28586203 | Role of the homeodomain transcription factor Bapx1 in mouse distal stomach development |
Q28585083 | Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo |
Q28254475 | Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients |
Q37704633 | S-nitrosylation of UCHL1 induces its structural instability and promotes α-synuclein aggregation. |
Q35838771 | SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer's disease amyloidosis and improves synaptic function |
Q48544898 | Selective expression of prion protein in peripheral tissues of the adult mouse |
Q44360675 | Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system. |
Q71812131 | Sensory nerve supply in the human subacromial bursa |
Q34646537 | Serotonin and the 5-HT(2B) receptor in the development of enteric neurons. |
Q35570888 | Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study |
Q34138549 | Similarities and differences in the innervation of mystacial vibrissal follicle-sinus complexes in the rat and cat: a confocal microscopic study |
Q36854630 | Skin biopsy in the management of peripheral neuropathy |
Q46438842 | Somatosensory organization and behavior in naked mole-rats: II. Peripheral structures, innervation, and selective lack of neuropeptides associated with thermoregulation and pain |
Q34551647 | Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins |
Q34502063 | Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1 |
Q44140058 | Study of rat hypothalamic proteome by HPLC/ESI ion trap and HPLC/ESI-Q-TOF MS. |
Q37279325 | Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates. |
Q28279309 | Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer |
Q43581283 | Sympathetic hyperinnervation of the uterus in the estrogen receptor alpha knock-out mouse |
Q28354326 | Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro |
Q36007472 | Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy |
Q33943560 | Taste cell function. Structural and biochemical implications |
Q34917256 | Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel |
Q42369990 | The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease |
Q37157230 | The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity. |
Q34157005 | The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility |
Q26767879 | The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury |
Q36020204 | The aggravating role of the ubiquitin-proteasome system in neurodegeneration |
Q73551102 | The alpha1 subunit of laminin-1 promotes the development of neurons by interacting with LBP110 expressed by neural crest-derived cells immunoselected from the fetal mouse gut |
Q28591458 | The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunction |
Q27679250 | The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK) |
Q38122985 | The complexity of recognition of ubiquitinated substrates by the 26S proteasome |
Q47658921 | The current state of biomarkers of mild traumatic brain injury |
Q24629152 | The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling |
Q36221083 | The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer |
Q33340463 | The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology |
Q46156813 | The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis |
Q24535191 | The discovery of ubiquitin-dependent proteolysis |
Q53432790 | The exclusive effects of chaperonin on the behavior of proteins with 52 knot. |
Q31157183 | The expression and significance of neuronal iconic proteins in podocytes |
Q48462486 | The expressions of epidermal growth factor receptor mRNA and protein gene product 9.5 in developing rat brain |
Q34769052 | The gene for human neurone specific ubiquitin C-terminal hydrolase(UCHLl, PGP9.5) maps to chromosome 4p14 |
Q74592188 | The genetics of Parkinson's disease |
Q45037344 | The immunolocalisation of the neuroendocrine specific protein PGP9.5 during neurogenesis in the rat |
Q42525795 | The influence of chemical sympathectomy on pain responsivity and alpha 2-adrenergic antinociception in neuropathic animals |
Q71650075 | The innervation of the mystacial pad in the adult rat studied by anterograde transport of HRP conjugates |
Q72711581 | The innervation of the mystacial pad of the rat as revealed by PGP 9.5 immunofluorescence |
Q41958129 | The innervation of the splenic capsule in the guinea pig: an immunohistochemical and ultrastructural study. |
Q39977138 | The role of PGP9.5 as a tumor suppressor gene in human cancer |
Q37781736 | The role of deubiquitinating enzymes in apoptosis |
Q38583099 | The role of deubiquitinating enzymes in spermatogenesis. |
Q26828378 | The role of deubiquitinating enzymes in synaptic function and nervous system diseases |
Q28205399 | The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders |
Q37866988 | The role of ubiquitylation in nerve cell development |
Q31014920 | The spatiotemporal relationship among Schwann cells, axons and postsynaptic acetylcholine receptor regions during muscle reinnervation in aged rats |
Q24527361 | The structure of the human gene encoding protein gene product 9.5 (PGP9.5), a neuron-specific ubiquitin C-terminal hydrolase |
Q45935293 | The three-dimensional distribution of nerves along the entire intrapulmonary airway tree of the adult rat and the anatomical relationship between nerves and neuroepithelial bodies. |
Q34774553 | The ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons |
Q29618638 | The ubiquitin-proteasome proteolytic pathway |
Q38075859 | The ubiquitin-proteasome system in retinal health and disease. |
Q47807766 | The ubiquitin-specific protease family from Arabidopsis. AtUBP1 and 2 are required for the resistance to the amino acid analog canavanine |
Q37201976 | The value of immunohistochemistry on paraffin wax embedded tissue sections in the differentiation of small lymphocytic and mantle cell lymphomas |
Q38290759 | Therapeutic strategies in Parkinson's disease: what we have learned from animal models |
Q38062499 | Transcriptional and post-transcriptional regulation of β-secretase. |
Q39052627 | Transcriptional regulation of human USP24 gene expression by NF-kappa B. |
Q36861432 | Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration |
Q46974852 | Traumatic brain injuries. |
Q37519476 | Trophic factor and hormonal regulation of neurite outgrowth in sensory neuron-like 50B11 cells |
Q27931184 | UBA 1: an essential yeast gene encoding ubiquitin-activating enzyme |
Q27933109 | UBC1 encodes a novel member of an essential subfamily of yeast ubiquitin-conjugating enzymes involved in protein degradation. |
Q38829786 | UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein |
Q50982636 | UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment. |
Q43980721 | UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices |
Q36375134 | UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer |
Q36727872 | UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma. |
Q48369163 | UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer. |
Q37249509 | UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance |
Q31077544 | UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan |
Q28118734 | UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: evidence of interplay between the ubiquitin/proteasome system and autophagy |
Q36562144 | UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression |
Q34444406 | UCHL1 regulates ubiquitination and recycling of the neural cell adhesion molecule NCAM. |
Q50296505 | UCHL1, UCHL3 cleave ubiquitin adducts |
Q64883693 | UCHL1/PGP 9.5 Dynamic in Neuro-Immune-Cutaneous Milieu: Focusing on Axonal Nerve Terminals and Epidermal Keratinocytes in Psoriatic Itch. |
Q38985872 | USP40 gene knockdown disrupts glomerular permeability in zebrafish |
Q47321547 | Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB. |
Q36812366 | Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity |
Q92686693 | Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks |
Q26741828 | Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction |
Q39024141 | Ubiquitin C-terminal hydrolase L1 interacts with choline transporter in cholinergic cells |
Q34228778 | Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions |
Q48892814 | Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory |
Q48051302 | Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia |
Q47169349 | Ubiquitin C-terminal hydrolase isozyme L1 is associated with shelterin complex at interstitial telomeric sites. |
Q36091119 | Ubiquitin C-terminal hydrolase l1 in tumorigenesis |
Q34163790 | Ubiquitin C-terminal hydrolase l1 is expressed in mouse pituitary gonadotropes in vivo and gonadotrope cell lines in vitro |
Q40794803 | Ubiquitin C-terminal hydrolase-L1 (PGP9.5) expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines, neurotrophic factors or heat stress |
Q39257016 | Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries |
Q92035644 | Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers |
Q33799710 | Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation |
Q34838590 | Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy |
Q35147643 | Ubiquitin carboxyl terminal hydrolyase L1-suppressed autophagic degradation of p21WAF1/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferation |
Q35050009 | Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts |
Q33667738 | Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction |
Q47592158 | Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications |
Q24318689 | Ubiquitin dimers control the hydrolase activity of UCH-L3 |
Q40794812 | Ubiquitin in neurodegenerative diseases |
Q27661287 | Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation |
Q48451497 | Ubiquitin, PGP 9.5 and dense body formation in trimethyltin intoxication: differential neuronal responses to chemically induced cell damage |
Q37897536 | Ubiquitin, cell stress and diseases of the nervous system |
Q39271369 | Ubiquitin-based probes prepared by total synthesis to profile the activity of deubiquitinating enzymes |
Q34019149 | Ubiquitin-mediated proteolysis in learning and memory |
Q48812205 | Ubiquitin-mediated stress response in a rat model of brain transient ischemia/hypoxia |
Q35186220 | Ubiquitination in postsynaptic function and plasticity |
Q43902847 | Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form |
Q42478519 | Ultrastructural localization of PGP 9.5 and ubiquitin immunoreactivities in rat ductus epididymidis epithelium |
Q47986554 | Unique localization of protein gene product 9.5 in type B synoviocytes in the joints of the horse |
Q36878887 | Unique spindle cells in the involved ileal segment of rats with congenital aganglionosis |
Q42512400 | Uveal spindle cell tumor of blue-eyed dogs: an immunohistochemical study |
Q35723883 | Visualization of Sensory Neurons and Their Projections in an Upper Motor Neuron Reporter Line. |
Q46802821 | cDNA cloning, sequence identification and tissue expression distribution of three novel porcine genes: UCHL3, RIT1 and CCND3. |
Q47130601 | cPKCγ-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway. |
Q36910190 | β-Amyloid (Aβ) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1. |
Q34448671 | β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency |
Search more.